Multiple Dose Study of SHR4640 in Healthy Subjects
Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to assess the tolerance, pharmacokinetic and pharmacodynamic
properties of multiple dose adminstration of SHR4640 in healthy volunteers.